Hillenbrand ( (HI) ) has provided an announcement.
On February 5, 2025, Hillenbrand announced its fiscal first-quarter 2025 results and the majority sale of its Milacron injection molding and extrusion business to an affiliate of Bain Capital. The company’s revenue was $707 million, a 9% decrease from the previous year, and adjusted EPS fell to $0.56. The transaction aligns with Hillenbrand’s transformation strategy to enhance its margin profile and focus on high-growth sectors, with net proceeds aimed at reducing debt. The sale reflects a strategic shift away from previously declining segments and positions Hillenbrand for future growth in less cyclical markets.
More about Hillenbrand
Hillenbrand, Inc., headquartered in Batesville, Indiana, is a global provider of highly-engineered processing equipment and solutions. The company focuses on industries such as food, health, and nutrition, with a strategy aiming at higher growth opportunities and reducing cyclical dependencies.
YTD Price Performance: 10.94%
Average Trading Volume: 431,303
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.38B
See more insights into HI stock on TipRanks’ Stock Analysis page.